Everolimus drug-eluting stent performance in patients with long coronary lesions: The multicenter Longprime registry.
José Francisco Díaz FernándezSantiago Jesús Camacho FreireJuan Carlos Fernández GuerreroNicolas DelarcheChristophe BretelleJavier Zueco GilRamón López PalopBruno García Del BlancoVicente Mainar TelloFranck AlbertPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
In this real-world population, the Xience Prime EES performs extremely well in long lesions, with a very low rate of both MACE and ST.